Choosing a drug development partner you trust to execute your study is a key part of most clinical development programs. Even the most carefully selected partner can fail to deliver. Staff turnover, acquisitions, capacity limitations – there are many reasons your CRO may no longer be able to fulfill your original plans.
So, how do you know when it’s time to transition your study to another CRO? It’s a difficult decision, and one that should be considered carefully.